Zomedica Corp. (NASDAQ:ZOM) | Finanzwire

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Home
Companies
Zomedica Corp.

BRIEF

published on 12/23/2024 at 12:35, 11 months 12 days ago

Zomedica Expands TRUFORMA Platform with Two New Canine Assays

Veterinary Health TRUFORMA Platform Canine Diagnostics NT-proBNP Test Progesterone Assay
PRESS RELEASE

published on 12/23/2024 at 12:30, 11 months 12 days ago

Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone
Zomedica launches two new assays for TRUFORMA Platform - canine NT-proBNP and progesterone tests for dogs. These assays provide precise in-clinic results for cardiac and reproductive conditions

Zomedica TRUFORMA Platform NT-proBNP Test Canine Assays Progesterone Testing
BRIEF

published on 12/19/2024 at 12:35, 11 months 16 days ago

Zomedica Names Scott A. Jordan as New CFO

Zomedica Veterinary Health Animal Health Finance Leadership Scott A. Jordan
PRESS RELEASE

published on 12/19/2024 at 12:30, 11 months 16 days ago

Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer
Zomedica appoints seasoned executive Scott A. Jordan as EVP Finance and CFO, bringing 30 years of industry experience. CEO Larry Heaton welcomes him to the leadership team

Zomedica Leadership Team Animal Health Executive Scott A. Jordan
BRIEF

published on 11/27/2024 at 12:35, 1 year ago

Zomedica to Showcase at NobleCon20 Equity Conference

Investor Conference Zomedica Veterinary Health Equity Growth NobleCon20
PRESS RELEASE

published on 11/27/2024 at 12:30, 1 year ago

Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024
Zomedica Corp. CEO Larry Heaton to present and host meetings with investors at NobleCon20. Company offers veterinary health solutions for animals

Zomedica Corp. Veterinary Health Larry Heaton Animal Healthcare NobleCon20
BRIEF

published on 11/14/2024 at 12:35, 1 year ago

Zomedica Launches Equine Insulin Assay on TRUFORMA Platform

Zomedica Veterinary Diagnostics TRUFORMA Platform Equine Health Equine Insulin Assay
PRESS RELEASE

published on 11/14/2024 at 12:30, 1 year ago

Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform
Zomedica launches TRUFORMA Insulin assay for equine plasma, providing rapid results in 18 minutes for diagnosing and monitoring insulin levels in horses, aiding in treatment decisions for equine metabolic syndrome and PPID

Zomedica TRUFORMA Insulin Assay Equine Plasma Horse Healthcare
BRIEF

published on 11/12/2024 at 12:35, 1 year ago

Noble Capital Markets Initiates Coverage on Zomedica

Zomedica Veterinary Health Noble Capital Markets Equity Research Channelchek
PRESS RELEASE

published on 11/12/2024 at 12:30, 1 year ago

Noble Capital Markets Initiates Equity Research Coverage on Zomedica
Zomedica Corp. engages Noble Capital Markets for equity research coverage. Learn about their innovative animal healthcare products & market growth

Zomedica Corp. Noble Capital Markets Animal Healthcare Veterinary Equity Research Coverage

Accesswire

Published on 12/05/2025 at 02:35, 5 hours 15 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 20 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 50 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 45 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 50 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 50 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 20 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 59 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 25 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 35 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 50 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 5 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 6 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE